Oligonucleotide analogs with L-and D-lysine residues incorporated in internucleotide linkages were synthesized and their affinity toward complementary DNA was studied. Stability of the duplexes formed by the modified oligonucleotides and their wild-type complements appeared to be close to that of the isosequential unmodified duplex, oligonucleotides carrying D-lysine residues forming generally more stable duplexes than L-lysine derivatives.
INTRODUCTION
Modified oligonucleotides (ONs) have become an important instrument in molecular biology experiments. ON analogs are extensively used for manipulation of gene expression via antisense or RNA interference mechanisms [1] [2] [3] [4] [5] [6] [7] [8] . However, the current ON analogs display limitations and there is a strong demand for new modified ONs. Much effort has been recently devoted to the problem of introduction of aminoalkyl side chains in ONs. This modification finds application in functionalization of nucleic acid aptamers and catalysts as well as nucleic acid labeling [9] [10] [11] . Furthermore, aminoalkyl-ONs display cationic side chains at appropriate pH and therefore can form with native DNA duplexes or triplexes with increased stability under certain conditions [12] [13] [14] [15] . Most popular sites for appending amino-or aminoalkyl functionalities are 5-position of pirimidines [16, 17] and 2'-position of ribose [18, 19] . In this paper, we describe ON analogs in which aminoalkyl functionalities are introduced via peptide internucleotide linkages. Peptide fragments are known to protect ON analogs from nuclease digestion and facilitate their cellular uptake, thus helping to overcome the two main impediments in the use of ON-based therapeutics [20, 21] . In our previous work we have reported a general method for incorporation of hydrophobic amino acid residues in ON strands [22, 23] . Here we describe adaptation of this method for preparation of L-and D-lysine derivatives (Scheme 1).
RESULTS AND DISCUSSION
Dinucleoside phosphoramidite blocks with trifluoroacetyl-protected -amino functionalities (Scheme 2) were prepared and used in automated ON synthesis. Treatment with NH 3 at the end of the ON synthesis yielded ON analogs with free -amino groups. Compounds 3a, 3b, key intermediates in the synthesis of target dinucleosides 9a, 9 b, were prepared via condensation of 3'-amino-3'-deoxy-5'-O-dimethoxytritylthymidine 1 with L-and D-lysine derivatives 2a, 2b in the presence of DCC and NHS (4 °C, 24 h). The usage of DCC and NHS enables avoidance of epimerization at -carbon atoms of amino acid residues, observed when using other condensing agents (about 30% epimerization, determined by 1 H-NMR, occurred when BOP was used). Compounds 3a, 3b were obtained in a yield of 83%. Optical purity of 3a, 3b was no less than 98% (determined by 1 H-NMR spectroscopy). Trifluoroacetyl protection was removed by treatment with K 2 CO 3 in a methanol/water mixture under reflux (4 h) to give compounds 4a, 4b, bearing free -amino groups, in a yield of 71-80%. The latter were condensed with 3'-O-(tbutyldimethylsilyl)thymidine 5'-carboxylc acid 5 (prepared following the published procedure [22] ) in the presence of BOP and TEA in CH 2 Cl 2 (20 °C, 1 h) to give dinucleoside analogs 6a, 6b in a yield of 84-89%. Epimerization via the 5(4H)-oxazolone mechanism not being possible at this stage, BOP was chosen as a condensing agent since it affords higher yields of 6a, 6b. Benzyloxicarbonyl protection was substituted for trifluoroacetyl protection without isolation of intermediate dinucleosides with free -amino groups. Dinucleosides 6a, 6b were deprotected by hydrogenation with ammonium formate in methanol in the presence of 10% Pd/C (reflux, 3h). Subsequent treatment with ethyl trifluoroacetate in the presence of TEA in methanol gave triflouroacetylated dinucleosides 7a, 7b in a yield of 80-82%. The silyl protection was removed with 0.5 M TBAF in THF (20°C, 4 h). Resulting dinucleosides 8a, 8b with free 3'-hydroxyl groups were treated with 2-cyanoethyl-N,N,N',N'-tetraisopropylphosphoramidite in the presence of terazole and pyridine in dichloromethane (20°C, 2 h) to give amidites 9a, 9b in a yield of 64-65%. Dinucleosides 6a,b -9a,b were characterized by MALDI-TOF mass spectrometry and the structures of 6a,b -8a,b were confirmed by COSY NMR spectroscopy.
COSY-spectra enabled unambiguous assignment of signals to protons of lysine, thymidine 5'-carboxylc acid and 3'-amino-3'-deoxythymidine moieties (Fig. 1) .
Dinucleoside amidite blocks 9a, 9b were used in the synthesis of modified ONs on an automated synthesizer following standard phosphoramidite protocols. Coupling time was increased to 15 minutes for modified phosphoramidites. No decrease in coupling efficiency was observed (98-99% step-wise coupling yields). Along with the modified ONs, isosequential and complementary wildtype ONs were synthesized. Purification of the ONs was carried out by reverse-phase HPLC. All the ONs were characterized by MALDI-TOF mass spectrometry ( Table 1) .
Thermal dissociation of the modified duplexes and their wild-type counterpart was measured. The resulting curves enabled evaluation of melting temperatures of the duplexes. The results are summarized in Table 2 .
As evident from Table 2 , ONs carrying D-lysine residues generally form more stable duplexes than L-lysine derivatives ( m = +0.4°C and -0.3°C per modification, on an average, respectively 1 ). The effect of the modification on duplex stability depends on its position. Terminal modifications tend to increase duplex stability, while modifications in the middle of the strand have small destabilizing effect, more significant in the case of the Llysine derivative.
CONCLUSION
In summary, we have described the facile synthesis of the novel ON analogs carrying L-and D-lysine residues in internucleotide linkages. The effect of the modifications on 1 Average m per modification was calculated as a sum of all corresponding m values reported in Table 2 divided by the total number of modifications. duplex stability has been assessed. Melting temperatures of the modified duplexes appeared to be close to that of the isosequential native duplex. Thus, the novel analogs meet the stability criterion set for modified ONs and could become a promising tool for the development of gene-targeted therapeutics. Considering that -amino groups of lysine residues in the novel analogs are accessible for conjugation reactions, such as fluorescent labeling, we believe, these analogs could also find application in diagnostics and in the study of biological functions of nucleic acids.
EXPERIMENTAL
All reagents were commercially available and used without further purification. 3'-Azydo-3'-deoxythymidine was provided by Association AZT (Russia). Dichloromethane was dried by distillation from phosphorus pentaoxide, pyridine was distilled from calcium hydride, and THF was distilled from lithium alumohydride prior to use. Silica gel flesh column chromatography was performed on silica gel Kieselgel 60 (0.040-0.063 mm, Merck). TLC was performed on silica gel Kieselgel 60 F 254 precoated plates (Merck) with detection by UV using the following solvent systems (compositions expressed as v/v): ethanolmethylene chloride 1:65 (A), 1:32 (B), 1: 19 (C), 1:12 (D), 1:9 + 0.1% TEA (E).
1 H NMR spectra were recorded on a Bruker AMXIII-400 NMR spectrometer on solutions in deuterated dimethyl sulfoxide (DMSO-d6). Chemical shifts are given in parts per million (ppm). The coupling constants (J) are given in Hz. The signals were assigned using COSY experiments. Abbreviations used: cT (thymidine 5'-carboxylc acid moiety), Ta (3'-deoxy-3'-aminothymidine moiety). The 1 H NMR data were processed and presented using MestReNova version 6.2.0 (Mestrelab Research SL). MALDI-TOF mass spectra were acquired on a Kratos MS-30 spectrometer using linear flight path.
ONs were synthesized on an Aplied Biosystem DNA synthesizer 3400 using standard phosphoramidite protocols and purified using preparative scale reverse-phase HPLC on a 250 mm x 4.0 mm 2 Hypersil C18 column with detection at 260 nm. Chromatography of dimethoxytrytil-protected ONs was performed using 10-50% gradient of CH 3 CN in 0.05 M TEAA. Melting curves of the duplexes were recorded on a Shimadzu UV 160-A spectrophotometer, equipped with a thermostatic system, in 20 mM sodium phosphate buffer, 100 mM NaCl, 01 mM EDTA, pH 7.0, concentration of each duplex being 2.5·10 -6 M. Samples were denatured at 95°C for 5 min and slowly cooled to 20°C prior to measurements. A 260 (duplex absorbance) was measured as a function of temperature. It was registered every 0.5°C from 20 to 70°C. Thermodynamic parameters of duplex formation were obtained by performing nonlinear regression analysis using DataFit version 9.0.059 (Oakdale Engineering, US). The calculation method taking into account temperature dependence of UV absorbance of duplexes and single strands was applied.
N--Benzyloxycarbonyl-N--trifluoroacetyl-L-lysine (2a).
To a stirred suspension of N--benzyloxycarbonyl-Llysine [24] (2.8 g, 10 mmol) in 30 mL of abs. MeOH, ethyl trifluoroacetate (2.84 g, 2.4 mL, 20 mmol) and TEA (2.02 g, 2.8 mL, 20 mmol) were added. The mixture was stirred for 24 h. Solvent was evaporated, the residue was dissolved in 50 mL of ethyl acetate, washed with water, 10% NaHSO 4 , water, dried over Na 2 SO 4 Nucleoside 3a (730 mg, 0 .809 mmol) was dissolved in methanol (15 mL), water (1.5 mL) and K 2 CO 3 (550 mg, 4 mmol) were added. The mixture was refluxed for 4 h, then cooled, diluted with water (50 mL) and extracted with chloroform (3 50 mL). Combined organic layers were washed with water (30 mL), dried over Na 2 SO 4 , filtered and evaporated. The residue was purified by CC in 7 -10% of ethanol in CH 2 Cl 2 + 0.1% TEA to give 4a as a hard foam (468 mg, 71.7% yield). R f = 0.37 (Solvent system E). Nucleoside 4a (1 g, 1. 2 mmol) was suspended in dry CH 2 Cl 2 (12 mL), 5'-carboxynucleoside 5 (489 mg, 1.3 mmol), TEA (392 DL, 2.8 mmol) and BOP (619 mg, 1.4 mmol) were added. The mixture was stirred for 1 h at 20 ° , then diluted with water (50 mL) and extracted with ethyl acetate (3 40 mL). Combined organic layers were washed with water (30 mL) and saturated NaHCO 3 (30 mL), dried over Na 2 SO 4 , filtered and evaporated. The residue was purified by silica gel flesh column chromatography in 4% of ethanol in CH 2 Cl 2 + 0.1% TEA to give 6a as a hard foam (1.218 g, 87.6% yield). R f = 0.35 (Solvent system C). . To a stirred solution of dinucleoside 6a (659 mg, 0.56 mmol) in dry methanol (10 mL), ammonium formate (150 mg, 2.3 mmol) and 10 % Pd/C (66 mg) were added. The mixture was refluxed for 3 h, then cooled to r.t. and filtered through Celite. Ethyl trifluoroacetate (203 mL, 1.70 mmol) and TEA (236 mL, 1.70 mmol) were added to a filtrate and the mixture was stirred for 2 h at 20 °. Methanol was evaporated, the residue was dissolved in ethyl acetate (50 mL), washed with water (30 mL) and saturated NaHCO 3 (30 mL). The organic layer was dried over Na 2 SO 4 , filtered and evaporated. The residue was purified by silica gel flesh column chromatography in 3% of ethanol in CH 2 Cl 2 + 0.1% TEA to give 7a as a hard foam (520 mg, 82% yield). R f = 0.53 (Solvent system A). 1 H NMR: 11.302 (2 H, s, H3 Ta, H3 cT), 9.336 (1 H, t, J 5.6, -NH L-Lys), 3 H5'a Ta signal is hidden under HOD signal. Identification by COSY-spectrum. 8 . 425 (1 H, d, J 7.8, 3'-NH Ta), 8.224 (1 H, d, J 8.1, - N-[(2R)-1-{(5'-O-(4,4'-Dimethoxytrityl)-3'-deoxythymidine-3'-yl)amino}-1-oxo-6-trifluoracetamidohexan-2 . Dinucleoside 8a (492 mg, 0.49 mmol) and tetrazole (39 mg, 0.55 mmol) were evaporated with dry pyridine (2 5 mL), dissolved in dry CH 2 Cl 2 (5 mL), 2-cyanoethyl-N,N,N',N'-tetraisopropylphosphoramidite (127.5 OL, 0.55 mmol) was added, and the mixture was stirred for 2 h at 20 °. TEA (0.1 mL) was added, the mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 20 mL). Combined organic layers were washed with NaHCO 3 (30 mL) and water (30 mL). The organic layer was dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel flesh column chromatography in 3-5% of ethanol in CH 2 Cl 2 + 0.1% TEA to give 9a as a hard foam (386 mg, 65.4% yield). R f = 0.48 (Solvent system C). 31 
(5S)-Benzyl 6-{(5'-O-(4,4'-dimethoxytrityl)-3'-deoxythymidine-3'-yl)amino}-6-oxo-5-aminohexylcarbamate (4 ).

N-[(2S)-6-Benzyloxycarboxamido-1-{(5'-O-(4,4'-dimethoxytrityl)-3'-deoxythymidine-3'-yl)amino}-1-oxohexan-2-yl]-3'-O-(tert-butyldimethylsilyl)thymidine-5'-carboxamide (6 ).
